Ascendis Pharma
ASND
$143.18
Share price
-1.14%
Change (1 day)
79.49%
Change (1 year)
Categories
Operating Margin for Ascendis Pharma (ASND)
Operating Margin as of April 2024 (TTM): -609.82%
According to Ascendis Pharma 's latest financial reports and stock price the company's current Operating Margin is -609.82%. At the end of 2022 the company had an Operating Margin of -1,129.12%.
Operating Margin history for Ascendis Pharma from 2014 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -1,129.12% | -77.13% |
| 2021 | -4,936.28% | -18.12% |
| 2020 | -6,028.68% | 269.46% |
| 2019 | -1,631.78% | 32.31% |
| 2018 | -1,233.26% | -84.83% |
| 2017 | -8,129.02% | 444.76% |
| 2016 | -1,492.23% | 260.81% |
| 2015 | -413.57% | 459.29% |
| 2014 | -73.95% | -420.75% |
| 2013 | 23.05% | 179.58% |
| 2012 | 8.25% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | -20.79% | -96.59% | 🇺🇸 USA |
 Affimed
AFMD | -210.66% | -65.46% | 🇩🇪 Germany |
 Advaxis ADXS | -549.75% | -9.85% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.